Valuation: GENFIT

Market Cap 46Cr 51Cr 42Cr 39Cr 73Cr 4.93TCr 74Cr 514.17Cr 199.24Cr 2.52TCr 192.36Cr 188.19Cr 8.08TCr P/E 2026 *
35.2x
P/E 2027 * 97.3x
Enterprise Value 40Cr 45Cr 38Cr 34Cr 65Cr 4.37TCr 65Cr 456.45Cr 176.87Cr 2.24TCr 170.76Cr 167.06Cr 7.17TCr EV / Sales 2026 *
4.31x
EV / Sales 2027 * 2.98x
Free-Float
86.89%
Yield 2026 *
-
Yield 2027 * -
1 day-5.24%
1 week-14.07%
Current month-9.05%
1 month-35.80%
3 months+3.43%
6 months-0.17%
Current year+69.77%
1 week 8.89
Extreme 8.89
9.94
1 month 8.89
Extreme 8.89
13.64
Current year 5.2
Extreme 5.205
14.34
1 year 3.61
Extreme 3.608
14.34
3 years 3.19
Extreme 3.19
14.34
5 years 3.19
Extreme 3.19
14.34
10 years 3.19
Extreme 3.19
14.34
Manager TitleAgeSince
Chief Executive Officer 58 16/09/2019
Director of Finance/CFO 52 22/04/2021
Chief Tech/Sci/R&D Officer - 27/11/2025
Director TitleAgeSince
Chairman 70 16/06/2017
Director/Board Member 54 15/09/1999
Director/Board Member 58 16/06/2017
Change 5-day change 1-year change 3-year change Capi.($)
-5.24%-14.07% - - 51Cr
+4.16%+3.04%+49.37%+94.17% 7.42TCr
-3.11%-3.53%+20.19%+81.44% 5.74TCr
+0.89%-0.63%+2.17%+36.19% 4.76TCr
+0.36%+0.81%+342.39%+742.40% 4.43TCr
-0.96%-4.50%+24.96%+35.38% 4.25TCr
-0.20%-0.77%+4.13%+105.50% 4.07TCr
-0.54%+2.93%+9.31%+50.41% 3.1TCr
-2.68%+2.92%+29.33%+22.72% 2.85TCr
+0.05%-1.64%-8.14%-11.37% 2.43TCr
Average -0.73%-0.59%+52.63%+128.54% 4.34TCr
Weighted average by Cap. +0.11%-0.84%+56.96%+138.26%

Financials

2026 *2027 *
Net sales 9.38Cr 11Cr 8.75Cr 7.98Cr 15Cr 1.01TCr 15Cr 105.91Cr 41Cr 518.65Cr 40Cr 39Cr 1.66TCr 13Cr 15Cr 12Cr 11Cr 21Cr 1.41TCr 21Cr 146.69Cr 57Cr 718.36Cr 55Cr 54Cr 2.31TCr
Net income 1.84Cr 2.07Cr 1.72Cr 1.57Cr 2.95Cr 199.11Cr 2.98Cr 21Cr 8.05Cr 101.79Cr 7.78Cr 7.61Cr 326.68Cr 1.04Cr 1.17Cr 96.76L 88.19L 1.66Cr 112.16Cr 1.68Cr 12Cr 4.54Cr 57Cr 4.38Cr 4.29Cr 184.02Cr
Net Debt -5.11Cr -5.75Cr -4.77Cr -4.35Cr -8.2Cr -552.96Cr -8.28Cr -58Cr -22Cr -282.68Cr -22Cr -21Cr -907.22Cr -6.76Cr -7.6Cr -6.31Cr -5.75Cr -11Cr -730.96Cr -11Cr -76Cr -30Cr -373.68Cr -29Cr -28Cr -1.2TCr
Logo GENFIT
GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).
Employees
161
Date Price Change Volume
02/26/02 €9.040 -5.24% 2,552
01/26/01 €9.540 -4.02% 0
30/26/30 €9.940 +11.81% 359
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
9.100EUR
Average target price
17.48EUR
Spread / Average Target
+92.09%

Quarterly revenue - Rate of surprise